[Procalcitonin in pediatric emergencies: comparison with C-reactive protein, interleukin-6 and interferon alpha in the differentiation between bacterial and viral infections]

Presse Med. 2000 Jan 29;29(3):128-34.
[Article in French]

Abstract

Objective: Procalcitonin concentration increases in bacterial infections but remains low in viral infections and inflammatory diseases. The change is rapid and the molecule is stable making it a potentially useful marker for distinguishing between bacterial and viral infections.

Patients and methods: Procalcitonin (PCT) was determined with an immunoluminometric assay on plasma collected at admission in 436 infants and children hospitalized for bacterial or viral infection. It was compared with C reactive protein, interleukin-6 and interferon-alpha measured on the same sample.

Results: PCT was 41.3 +/- 77.4 micrograms/l in children with septicemia or bacterial meningitis (n = 53), 0.39 +/- 0.57 microgram/l in children with viral infection (n = 274) and 3.9 +/- 5.9 micrograms/l in children with a localized bacterial infection who had a negative blood culture (n = 109). PCT was > 1 microgram/l in 126 children with a localized or systemic bacterial infection (sensitivity 78%). PCT was < 1 microgram/l in 258 children with a viral infection (specificity 94%). For differenciation between viral and bacterial infections, CRP value > or = 20 mg/l, IL-6 > 100 pg/ml and interferon-alpha > 0 Ul/ml have 85, 48 and 76% sensitivity and 73, 85 and 92% specificity respectively.

Conclusions: In this study, a PCT value of 1 microgram/l or greater had better specificity, sensitivity and predictive value than CRP, IL-6 and interferon-alpha in children for distinguishing between viral and bacterial infections. PCT may be useful in pediatric emergency room for making decision about antibiotic treatments.

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Bacterial Infections / diagnosis*
  • Bacterial Infections / microbiology
  • C-Reactive Protein / pharmacology
  • C-Reactive Protein / therapeutic use*
  • Calcitonin / pharmacology
  • Calcitonin / therapeutic use*
  • Calcitonin Gene-Related Peptide
  • Child
  • Child, Preschool
  • Emergencies
  • Glycoproteins / pharmacology
  • Glycoproteins / therapeutic use*
  • Humans
  • Infant
  • Inflammation / diagnosis
  • Inflammation / microbiology*
  • Inflammation / virology
  • Interferon-alpha / pharmacology
  • Interferon-alpha / therapeutic use*
  • Interleukin-6 / pharmacology
  • Interleukin-6 / therapeutic use*
  • Protein Precursors / pharmacology
  • Protein Precursors / therapeutic use*
  • Virus Diseases / diagnosis*
  • Virus Diseases / virology

Substances

  • CALCA protein, human
  • Glycoproteins
  • Interferon-alpha
  • Interleukin-6
  • Protein Precursors
  • Calcitonin
  • C-Reactive Protein
  • Calcitonin Gene-Related Peptide